A subscription to JoVE is required to view this content. Sign in or start your free trial.
This article provides a detailed protocol for preparing a working solution of Gushukang granules for animal studies and GSK granule containing serum for in vitro experiments. This protocol can be applied to pharmacological investigations of herbal medicines as well as prescriptions for both in vivo and in vitro experiments.
Traditional Chinese herbal medicine plays a role as an alternative method in treating many diseases, such as postmenopausal osteoporosis (POP). Gushukang (GSK) granules, a marketed prescription in China, have bone-protective effects in treating POP. Before administration to the body, one standard preparation procedure is commonly required, which aims to promote the release of active constituents from raw herbs and enhance the pharmacological effects as well as therapeutic outcomes. This study proposes a detailed protocol for using GSK granules in in vivo and in vitro experimental assays. The authors first provide a detailed protocol to calculate the animal-appropriate dosages of granules for in vivo investigation: weighing, dissolving, storage, and administration. Second, this article describes protocols for micro-CT scanning and the measurement of bone parameters. Sample preparation, protocols for running the micro-CT machine and quantification of bone parameters were evaluated. Third, serum-containing GSK granules are prepared, and drug-containing serum is extracted for in vitro osteoclastogenesis and osteoblastogenesis. GSK granules were intragastrically administered twice per day to rats for three consecutive days. Blood was then collected, centrifuged, inactivated, and filtered. Finally, serum was diluted and used for performing osteoclastogenesis and osteoblastogenesis. The protocol described here can be considered a reference for pharmacological investigations of herbal prescription medicines, such as granules.
Traditional Chinese medicine (TCM) is one of the important complementary and alternative approaches to treat osteoporosis1,2. Water decoction is the basic and most commonly used form of the formula3. However, drawbacks also exist: bad taste, inconvenience for carriage, short shelf life and inconsistent protocols, limiting the uses as well as the curative effects. To avoid the above disadvantages as well as to pursue better effects, granules were developed and have been widely used4. Although many studies have explored the pharmacological mechanisms of one or more....
All of the experimental procedures were performed with the approval of Institutional Animal Care and Use Committee of the Shanghai University of TCM (SZY201604005).
1. Preparation and administration of GSK working solution
Micro-CT scanning results indicated that the OVX mice showed significant bone loss compared to saline control mice (Figure 1A). The intervention (90 days) of GSK granules greatly increased the BMD, particularly in the GSKM group (Figure 1B). The bone structure parameters, such as BMD, BV/TV, Tb.N, and Tb.Th, were quantified. GSK granule treatments led to increased BMD, BV/TV, Tb.N and Tb.Th but decreased Tb.Sp (
Granules of TCM agents have become one of the common choices for formulations or prescriptions. GSK granules are composed of several herbal medicines based on clinical experiences or the TCM theory, and they exert better curative effects with fewer side effects4. Compared with water decoction, the granules have these advantages: good taste, convenience of delivery, long-term storage, standard protocol and consistent curative effects, as well as higher productivity. Currently, granules are one of t.......
This study was supported by grants from the National Natural Science Foundation of China (81804116, 81673991, 81770107, 81603643, and 81330085), the program for Innovative Team, Ministry of Science and Technology of China (2015RA4002 to WYJ), Â the program for Innovative Team, Ministry of Education of China (IRT1270 to WYJ), Shanghai TCM Medical Center of Chronic Disease (2017ZZ01010 to WYJ), Three Years Action to Accelerate the Development of Traditional Chinese Medicine Plan (ZY(2018-2020)-CCCX-3003 to WYJ), and national key research development projects (2018YFC1704302).
....Name | Company | Catalog Number | Comments |
α-MEM | Hyclone laboratories | SH30265.018 | For cell culture |
β-Glycerophosphate | Sigma | G5422 | Osteoblastogenesis |
Caltrate (CAL) | Wyeth | L96625 | Animal interventation |
C57BL/6 mice | SLAC Laboratory Animal Co. Ltd. | Random | Ainimal preparation |
Dexamethsome | Sigma | D4902 | |
Dimethyl sulfoxide | Sigma | D2438 | Cell frozen |
Ethylene Diamine Tetraacetic Acid (EDTA) | Sangon Biotech | 60-00-4 | Samples treatmnet |
Fetal bovine serum | Gibco | FL-24562 | For cell culture |
Gushukang granules | kangcheng companyin china | Z20003255 | Herbal prescription |
Light microscope | Olympus BX50 | Olympus BX50 | Images for osteoclastogenesis |
L-Ascorbic acid 2-phosphate sequinagneium slat hyclrate | Sigma | A8960-5G | Osteoblastogenesis |
Microscope | Leica | DMI300B | Osteocast and osteoblast imagine |
M-CSF | Peprotech | AF-300-25-10 | Osteoclastogenesis |
Μicro-CT | Scanco Medical AG | μCT80 radiograph microtomograph | Bone Structural analsysis |
RANKL | Peprotech | 11682-HNCHF | Osteoclastogenesis |
Sprague Dawley | SLAC Laboratory Animal Co. Ltd. | Random | Blood serum collection |
Tartrate-Resistant Acid Phosphate (TRAP) Kit | Sigma-Aldrich | 387A-1KT | TRAP staining |
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved